The mechanism behind this increased susceptibility is not fully understood, but evidence suggests that overexpression of MUC5B by distal bronchiolar and alveolar epithelial cells in IPF patients may lead to mucociliary dysfunction, promoting the development of pulmonary fibrosis in experimental animals [8,11,12]. Here, MUC5B is linked to pulmonary fibrosis.